Kurzporträt
Mitarbeiterzahl: 50
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01.01.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 85 | 01.04.19 | |
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01.01.08 |
Ravi Limaye
BRD | Director/Board Member | 60 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 51 948 000 | 51 428 520 ( 99,00 %) | 0 | 99,00 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Laboratoires Negma SAS
Laboratoires Negma SAS Pharmaceuticals: MajorHealth Technology Laboratoires Negma SAS manufactures pharmaceutical products. It has products in the osteoarthritis, anti-hemorrhoids, anti-hypertension, rheumatology, phlebotonic, and vesical instability. The company also has manufacturing facilities in Europe. Laboratoires Negma S.A.S. was formerly known as Negma Lerads S.A.S. the company was founded in 1996 and is headquartered in Velizy Villacoublay, France |
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+22,69 % | 43,81 Mrd. | |
+24,92 % | 23,01 Mrd. | |
+18,00 % | 15,27 Mrd. | |
+8,91 % | 13,68 Mrd. | |
+42,72 % | 11,96 Mrd. | |
-7,21 % | 6,98 Mrd. | |
-0,05 % | 6,79 Mrd. | |
-8,87 % | 5,73 Mrd. | |
+12,22 % | 5,59 Mrd. |